Literature DB >> 50307

Staining of sulphatides in metachromatic leukodystrophy with Alcian blue at high salt concentrations.

I A Lampert, P D Lewis.   

Abstract

Alcian blue combines with purified sulphatide in 1.OM magnesium chloride. In tissue sections from patients with metachromatic leukodystrophy, sulphatide is stained by Alcian blue in 0.8 M magnesium chloride, and the staining can be abolished by prior treatment with chloroform and methanol. The simplicity of the technique, its specificity and ease of interpretation recommend Alcian blue staining at high salt concentrations as a routine method in the diagnosis of metachromatic leukodystrophy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50307      PMCID: PMC8334129          DOI: 10.1007/BF00499708

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  5 in total

1.  THE VISCERAL LESIONS OF METACHROMATIC LEUKODYSTROPHY.

Authors:  H J WOLFE; G G PIETRA
Journal:  Am J Pathol       Date:  1964-06       Impact factor: 4.307

2.  A CONTROLLED STUDY OF ENZYMIC ACTIVITIES IN THREE HUMAN DISORDERS OF GLYCOLIPID METABOLISM.

Authors:  J H AUSTIN; A S BALASUBRAMANIAN; T N PATTABIRAMAN; S SARASWATHI; D K BASU; B K BACHHAWAT
Journal:  J Neurochem       Date:  1963-12       Impact factor: 5.372

3.  METACHROMATIC FORM OF DIFFUSE CEREBRAL SCLEROSIS. IV. LOW SULFATASE ACTIVITY IN THE URINE OF NINE LIVING PATIENTS WITH METACHROMATIC LEUKODYSTROPHY (MLD).

Authors:  J AUSTIN; D MCAFEE; L SHEARER
Journal:  Arch Neurol       Date:  1965-05

4.  [Histological methods in differential diagnosis of leukodystrophy from lipoidosis].

Authors:  T VON HIRSCH; J PEIFFER
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1955

5.  Differential staining of acid glycosaminoglycans (mucopolysaccharides) by alcian blue in salt solutions.

Authors:  J E Scott; J Dorling
Journal:  Histochemie       Date:  1965-10-01
  5 in total
  1 in total

1.  The cornea in normal condition and in Groenouw's macular dystrophy.

Authors:  J François; V Victoria-Troncoso
Journal:  Doc Ophthalmol       Date:  1979-11-30       Impact factor: 2.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.